Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cattley, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cattley, R. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Peroxisome Proliferators and Receptor-Mediated Hepatic Carcinogenesis

Russell C. Cattley

Department of Pathology, Amgen Inc., Thousand Oaks, California 91320, USA, rcattley@ amgen.com

The peroxisome proliferators represent an important group of hepatic carcinogens in rodents that act via the nuclear receptor PPAR{alpha}. The primary role of PPAR{alpha} in mediating this response had led to the further characterization of potential events downstream that likely enable the carcinogenic response, including increased peroxisomal fatty acid beta oxidation and the modulation of hepatocellular replication and death, either generally or in preneoplastic lesions. A cooperative role of Kupffer cell activation has been proposed to function in the modulation of hepatocellular proliferation in rodent liver by peroxisome proliferators, but data that confirm or refute this proposal are mixed. Presently there is no evidence that links the Kupffer cell activation by peroxisome proliferators directly to the development of liver tumors. There are marked species differences in susceptibility to peroxisomal proliferation, and active investigation concerning the molecular basis of these differences continues.

Key Words: Peroxisome • liver • cancer.

References

  • Anderson, S.P., Dunn, C.S., Cattley, R., and Corton, J.C. (2001). Hepatocellular proliferation in response to a peroxisome proliferator does not require tnf{alpha} signaling. Carcinogenesis 22, 1843—51.[Abstract/Free Full Text]
  • Ashby, J., Brady, A., Elcombe, C.R., Elliott, B.M., Ishmael, J., Odum, J., Tugwood, J.D., Kettle, S., and Purchase, I.F.H. (1994). Mechanisticallybased human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Human Exper Toxicol 13(2), S1—117.
  • Blumcke, S., Schwartzkopff, W., Lobeck, H., Edmondson, N.A., Prentice, D.E., and Blane, G.F. (1983). Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients. Atherosclerosis 46(1), 105—16.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bojes, H.K., Germolec, D.R., Simeonova, P., Bruccoleri, A., Schoonhoven, R., Luster, M.I., and Thurman, R.G. (1997). Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis 18, 669—74.[Abstract/Free Full Text]
  • Bojes, H.K., and Thurman, R.G. (1996). Peroxisome proliferators activate Kupffer cells in vivo. Cancer Res 56, 1—4.[Abstract/Free Full Text]
  • Bunger, M.K., Moran, S.M., Glover, E., Thomae, T.L., Lahvis, G.P., and Lin, B.C. (2003). Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J Biol Chem 278(20), 17767—74.[Abstract/Free Full Text]
  • Butler, E.G., England, P.J., and Williams, G.M. (1988). Genetic differences in enzymes associated with peroxisome proliferation and hydrogen peroxide metabolism in inbred mouse strains. Carcinogenesis 9(8), 1459—63.[Abstract/Free Full Text]
  • Butler, E.G., Tanaka, T., Ichida, T., Maruyama, H., Leber, A.P., and Williams, G.M. (1988). Induction of hepatic peroxisome proliferation in mice by lactofen, a diphenyl ether herbicide. Toxicol Appl Pharmacol 93(1), 72—80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cattley, R.C. (2003). Regulation of cell proliferation and cell death by peroxisome proliferators. Micros Res Tech 61(2), 179—84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cattley, R.C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B.G., Marsman, D.S., Pastoor, T.A., Popp, J.A., Robinson, D.E., Schwetz, B., Tugwood, J., and Wahli, W. (1998). Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul Toxicol Pharmacol 27(1), 47—60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Choudhury, A.I., Chahal, S., Bell, A.R., Tomlinson, S.R., Roberts, R.A., Salter, A.M., and Bell, D.R. (2000). Species differences in peroxisome proliferation; mechanisms and relevance. Mutat Res 448, 201—12.[Web of Science][Medline] [Order article via Infotrieve]
  • Conway, J.G., Neptun, D.A., Garvey, L.K., and Popp, J.A. (1978). Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin. Cancer Res 47(18), 4795—800.
  • Conway, J.G., Tomaszewski, K.E., Olson, M.J., Cattley, R.C., Marsman, D.S., and Popp, J.A. (1989). Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis 10(3), 513—9.[Abstract/Free Full Text]
  • Cressman, D.E., Greenbaum, L.E., Deangelis, R.A., Ciliberto, G., Furth, E.E., Poli, V., and Taub, R. (1996). Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274(5291), 1379—83.[Abstract/Free Full Text]
  • de la Iglesia, F.A., Lewis, J.E., Buchanan, R.A., Marcus, E.L., and McMahon, G. (1982). Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis 43(1), 19— 37.
  • DeLuca, J.G., Doebber, T.W., Kelly, L.J., Kemp, R.K., Molon-Noblot, S., Sahoo, S.P., Ventre, J., Wu, M.S., Peters, J.M., Gonzalez, F.J., and Moller, D.E. (2000). Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice. Mol Pharmacol 58(3), 470—6.[Abstract/Free Full Text]
  • Diehl, A.M. (2000). Cytokine regulation of liver injury and repair. Immunol Rev 174, 160—71.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Escher, P., and Wahli, W. (2000). Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutation Research 448(2), 121—38.[Web of Science][Medline] [Order article via Infotrieve]
  • Fausto, N. (2000). Liver regeneration. J Hepatol 32(Suppl. 1), 19—31.[Web of Science][Medline] [Order article via Infotrieve]
  • Galloway, S.M., Johnson, T.E., Armstrong, M.J., and Ashby, J. (2000). The genetic toxicity of the peroxisome proliferator class of rodent hepatocarcinoge. Mutat Res 448(2), 153—8.[Web of Science][Medline] [Order article via Infotrieve]
  • Gariot, P., Barrat, E., Drouin, P., Genton, P., Pointel, J.P., Foliguet, B., Kolopp, M., and Debry, G. (1987). Morphometric study of human hepatic cell modifications induced by fenofibrate. Metabolism: Clin Exper 36(3), 203— 10.
  • Gervois, P., Pineda, T.I., Chinetti, G., Grotzinger, T., Dubois, G., Fruchart, J.C., Fruchart-Najib, J., Leitersdorf, E., and Staels, B. (1999). A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. Mol Endocrinol 13(9), 1535—49.[Abstract/Free Full Text]
  • Gibson, G.G., Orton, T.C., and Tamburini, P.P. (1982). Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). Biochem J 203(1), 161—8.[Web of Science][Medline] [Order article via Infotrieve]
  • Hanefeld, M., Kemmer, C., and Kadner, E. (1983). Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 46(2), 239—46.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hess, R., Staubli, W., and Riess, W. (1965). Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 208(13), 856—8.[CrossRef][Medline] [Order article via Infotrieve]
  • Issemann, I., and Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347(6294), 645—50.[CrossRef][Medline] [Order article via Infotrieve]
  • Issemann, I., Prince, R.A., Tugwood, J.D., and Green, S. (1993). The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol 11(1), 37—47.[Abstract/Free Full Text]
  • Kakizaki, S., Yamamoto, Y., Ueda, A., Moore, R., Sueyoshi, T., and Negishi, M. (2003). Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR. Biochim Biophys Acta 1619(3), 239—42.[Medline] [Order article via Infotrieve]
  • Kluwe, W.M., Haseman, J.K., Douglas, J.F., and Huff, J.E. (1982). The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. J Toxicol Environ Health 10(4—5), 797— 815.[Web of Science][Medline] [Order article via Infotrieve]
  • Kurata, Y., Kidachi, F., Yokoyama, M., Toyota, N., Tsuchitani, M., and Katoh, M. (1998). Subchronic toxicity of Di(2-ethylhexyl)phthalate in common marmosets: lack of hepatic peroxisome proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia. Toxicol Sci 42, 49—56.[Abstract/Free Full Text]
  • Lake, B.G., Evans, J.G., Cunninghame, M.E., and Price, R.J. (1993). Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster. Environ Health Perspect 101(5), 241—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lake, B.G., Rumsby, P.C., Price, R.J., and Cunninghame, M.E. (2000). Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig. Mut Res 448(2), 213—25.[Web of Science][Medline] [Order article via Infotrieve]
  • Lambe, K.G., Woodyatt, N.J., Macdonald, N., Chevalier, S., and Roberts, R.A. (1999). Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter. Toxicol Lett 110(1—2), 119—27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lawrence, J.W., Wollenberg, G.K., and DeLuca, J.G. (2001). Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation. Carcinogenesis 22, 381—6.[Abstract/Free Full Text]
  • Lazarow, P.B., and De Duve, C. (1976). A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Nat Acad Sci USA 73(6), 2043—6.[Abstract/Free Full Text]
  • Ledda-Columbano, G.M., Curto, M., Piga, R., Zedda, A.I., Menegazzi, M., Sartori, C., Shinozuka, H., Bluethmann, H., Poli, V., and Columbano, A. (1998). In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene 17, 1039—44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lee, S.S., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., Fernandez-Salguero, P.M., Westphal, H., and Gonzalez, F.J. (1995). Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15, 3012—22.[Abstract]
  • Marsman, D.S. (1991). Peroxisome Proliferator Hepatocarcinogenesis in Rats, Dissertation, University of North Carolina, Chapel Hill, NC.
  • Marsman, D.S., Cattley, R.C., Conway, J.G., and Popp, J.A. (1988). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res 48, 6739—44.[Abstract/Free Full Text]
  • Marsman, D.S., Goldsworthy, T.L., and Popp, J.A. (1992). Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Carcinogenesis 13, 1011—7.[Abstract/Free Full Text]
  • Miller, R.T., Anderson, S.P., Corton, J.C., and Cattley, R.C. (2000). Apoptosis, mitosis and cyclophilin-40 expression in regressing peroxisome proliferator-induced adenomas. Carcinogenesis 21, 647— 52.[Abstract/Free Full Text]
  • Palmer, C.N., Hsu, M.H., Griffin, K.J., Raucy, J.L., and Johnson, E.F. (1998). Peroxisome proliferator activated receptor-alpha expression in human liver. Mol Pharmacol 53, 14—22.[Abstract/Free Full Text]
  • Peters, J.M., Cattley, R.C., and Gonzalez, F.J. (1997). Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18, 2029—33.[Abstract/Free Full Text]
  • Pugh, G., Isenberg, J.S., Kamendulis, L.M., Ackley, D.C., Clare, L.J., Brown, R., Lington, A.W., Smith, J.H., and Klaunig, J.E. (2000). Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate, and clofibrate in cynomolgus monkeys. Toxicol Sci 56(1), 181—8.[Abstract/Free Full Text]
  • Reddy, J.K., Azarnoff, D.L., and Hignite, C.E. (1980). Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283(5745), 397—8.[CrossRef][Medline] [Order article via Infotrieve]
  • Reddy, J.K., Azarnoff, D.L., Svoboda, D.J., and Prasad, J.D. (1974). Nafenopin induced hepatic microbody peroxisome proliferation and catalase synthesis in rats and mice absence of sex difference in response. J Cell Biol 61(2), 344—58.[Abstract/Free Full Text]
  • Roberts, R.A. (2002). Evidence for cross talk between PPARalpha and p38 MAP kinase. Toxicol Sci 68(2), 270—4.[Free Full Text]
  • Roglans, N., Bellido, A., Rodriguez, C., Cabrero, A., Novell, F., Ros, E., Zambon, D., and Laguna, J.C. (2002). Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver. Clini Pharmacol Ther 72(6), 692—701.[CrossRef]
  • Rose, M.L., Germolec, D.R., Schoonhoven, R., and Thurman, R.G. (1997). Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 18, 1453—6.[Abstract/Free Full Text]
  • Rusyn, I., Tsukamoto, H., and Thurman, R.G. (1998). WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. Carcinogenesis 19, 1217—22.[Abstract/Free Full Text]
  • Rusyn, I., Yamashina, S., Segal, B.H., Schoonhoven, R., Holland, S.M., Cattley, R.C., Swenberg, J.A., and Thurman, R.G. (2000). Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Cancer Res 60, 4798—803.[Abstract/Free Full Text]
  • Tanaka, K., Smith, P.F., Stromberg, P.C., Eydelloth, R.S., Herold, E.G., Grossman, S.J., Frank, J.D., Hertzog, P.R., Soper, K.A., and Keenan, K.P. (1992). Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague—Dawley rats treated with tumorigenic doses of clofibrate. Toxicol Appl Pharmacol 116, 71—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Taub, R., Greenbaum, L.E., and Peng, Y. (1999). Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis 19, 117—27.[Web of Science][Medline] [Order article via Infotrieve]
  • Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L., and Green, S. (1992). The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11(2), 433—9.[Web of Science][Medline] [Order article via Infotrieve]
  • Wallenius, V., Wallenius, K., and Jansson, J.O. (2000). Normal pharmacologically-induced, but decreased regenerative liver growth in interleukin-6-deficient (IL-6–/–) mice. J Hepatol 33(6), 967—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ward, J.M., Peters, J.M., Perella, C.M., and Gonzalez, F.J. (1998). Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice. Toxicol Pathol 26, 240—6.[Abstract/Free Full Text]
  • Wong, C.W., McNally, C., Nickbarg, E., Komm, B.S., and Cheskis, B.J. (2002). Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99(23), 14783—8.[Abstract/Free Full Text]
  • Woodyatt, N.J., Lambe, K.G., Myers, K.A., Tugwood, J.D., and Roberts, R.A. (1999). The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs. Carcinogenesis 20(3), 369—72.[Abstract/Free Full Text]
  • Yamada, Y., and Fausto, N. (1998). Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Hepatology 28(4 PART 2), 401A.
  • Yamada, Y., Kirillova, I., Peschon, J.J., and Fausto, N. (1997). Initiation of liver gowth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Med Sci 94, 1441—6.
  • Yeldandi, A.V., Rao, M.S., and Reddy, J.K. (2000). Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat Res 448(2), 159—77.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 32, No. 2 suppl, 6-11 (2004)
DOI: 10.1080/01926230490451680
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. A. Gyamfi and Y.-J. Y. Wan
Mechanisms of Resistance of Hepatocyte Retinoid X Receptor {alpha}-Null Mice to WY-14,643-induced Hepatocyte Proliferation and Cholestasis
J. Biol. Chem., April 3, 2009; 284(14): 9321 - 9330.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
Q. Yang, T. Nagano, Y. Shah, C. Cheung, S. Ito, and F. J. Gonzalez
The PPAR{alpha}-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPAR{alpha}
Toxicol. Sci., January 1, 2008; 101(1): 132 - 139.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Q. Yang, S. Ito, and F. J. Gonzalez
Hepatocyte-restricted constitutive activation of PPAR{alpha} induces hepatoproliferation but not hepatocarcinogenesis
Carcinogenesis, June 1, 2007; 28(6): 1171 - 1177.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cattley, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cattley, R. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?